<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40669962</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1876-7605</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>13</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>14</Day></PubDate></JournalIssue><Title>JACC. Cardiovascular interventions</Title><ISOAbbreviation>JACC Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Randomized Comparison of Fractional Flow Reserve and Instantaneous Wave Free Ratio in Serial Disease.</ArticleTitle><Pagination><StartPage>1617</StartPage><EndPage>1627</EndPage><MedlinePgn>1617-1627</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcin.2025.05.033</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1936-8798(25)01621-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Fractional flow reserve (FFR) and the instantaneous wave-free ratio (iFR) identify arteries that benefit from percutaneous coronary intervention (PCI). FFR or iFR gradients on pullback are often used to predict the physiological result (FFR<sub>&#x394;</sub> or iFR<sub>&#x394;</sub>), but this approach is unvalidated.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to compare the accuracy of FFR<sub>&#x394;</sub>, iFR<sub>&#x394;</sub> and FFR<sub>calc</sub> (a mathematical solution incorporating interaction between lesions) for predicting post-PCI physiology in serial or diffuse disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with a focal target lesion and either a second focal lesion or a diffusely diseased segment in the same vessel were randomized to FFR- vs iFR-guided PCI (ISRCTN18106869). FFR and iFR pullbacks were performed, with operators blinded to one modality. Following target lesion PCI, FFR and iFR were remeasured. The primary outcome was the error in predicted post-PCI physiology compared with actual values.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 87 patients were randomized to FFR (n = 45) or iFR (n = 42). Median FFR and iFR were 0.70 (Q1-Q3: 0.62 to 0.78) and 0.81 (Q1-Q3: 0.68 to 0.90) at baseline and 0.82 (Q1-Q3: 0.74 to 0.87) and 0.89 (Q1-Q3: 0.83 to 0.93) after target lesion PCI. The predictive errors were 12% (6% to 17%) for FFR<sub>&#x394;</sub>, 4% (0% to 9%; P &lt; 0.001) for iFR<sub>&#x394;</sub>, and -5% (-18% to 8%; P = 0.427) for FFR<sub>calc</sub>. Significant residual disease was missed in 36% of cases with FFR<sub>&#x394;</sub>, 34% with iFR<sub>&#x394;</sub>, and 14% with FFR<sub>calc</sub>.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FFR and iFR pullback gradients overestimate the benefit of target lesion PCI and can miss residual ischemia in one-third of patients. FFR or iFR should be routinely repeated post-PCI in serial disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li Kam Wa</LastName><ForeName>Matthew E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre of Excellence, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezad</LastName><ForeName>Saad M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre of Excellence, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Modi</LastName><ForeName>Bhavik</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Glenfield Hospital, University Hospitals of Leicester NHS Trust &amp; University of Leicester, NIHR Leicester Biomedical Research, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demir</LastName><ForeName>Ozan M</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre of Excellence, King's College London, London, United Kingdom; Essex Cardiothoracic Centre, Mid and South Essex NHS Foundation Trust &amp; Anglia Ruskin University, Chelmsford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinton</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal Bournemouth Hospital, University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Howard</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre of Excellence, King's College London, London, United Kingdom; St. Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Silva</LastName><ForeName>Kalpa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre of Excellence, King's College London, London, United Kingdom; St. Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulati</LastName><ForeName>Ankur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St. Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Silva</LastName><ForeName>Ranil</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal Brompton Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Kane</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Royal Bournemouth Hospital, University Hospitals Dorset NHS Foundation Trust, Bournemouth, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douiri</LastName><ForeName>Abdel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Population Health &amp; Environmental Sciences, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collison</LastName><ForeName>Damien</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>West of Scotland Regional Heart &amp; Lung Centre, Golden Jubilee National Hospital, Clydebank, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curzen</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Southampton School of Medicine &amp; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collet</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Cardiovascular Center Aalst, Onze-Lieve-Vrouwehospitaal, Aalst, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>Divaka</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre of Excellence, King's College London, London, United Kingdom; St. Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. Electronic address: divaka.perera@kcl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Cardiovasc Interv</MedlineTA><NlmUniqueID>101467004</NlmUniqueID><ISSNLinking>1936-8798</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053805" MajorTopicYN="Y">Fractional Flow Reserve, Myocardial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006328" MajorTopicYN="Y">Cardiac Catheterization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="Y">Coronary Vessels</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronary physiology</Keyword><Keyword MajorTopicYN="N">fractional flow reserve</Keyword><Keyword MajorTopicYN="N">instantaneous wave-free ratio</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures This trial was funded by an unrestricted grant from Abbott Vascular. Drs Li Kam Wa, Ezad, and Perera are supported by British Heart Foundation grants FS/CRTF/22/24342, FS/CRTF/21/24118, and RE/18/2/34213. Dr Collet has received research grants from Coroventis Research and Abbott; and has received consultancy fees from Abbott and Philips. Dr O&#x2019;Kane has received honoraria and speaker fees from Philips. Drs Collison and Perera have received speaker fees from Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>17</Day><Hour>4</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>17</Day><Hour>4</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>20</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40669962</ArticleId><ArticleId IdType="doi">10.1016/j.jcin.2025.05.033</ArticleId><ArticleId IdType="pii">S1936-8798(25)01621-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>